dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 8. märts 2019
Viit
1.4-2/720-1
Registreeritud
8. märts 2019
Dokumendi liik
Sissetulev kiri
Adressaat
World Health Organization
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2019
Vastutaja
Kärt Sõber (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Rahvatervise osakond)
Lahendamise tähtaeg
15. aprill 2019

Failid

  • 📎Annual status update on measles and rubella elimination.pdf158 KB
  • 📎E-kiri.pdf450 KB
  • 📎ENG ASU 2018.pdf
  • 📎ENG Excel tool ASU 2018.pdf942 KB

Sisu (failidest)

Worksheet ASU Table 1.1. 1 1.1.1 c 1.1.1. d-f 2 1.1.4.1 a / 1.1.4.2 a 3 1.2 c 4 1.3.1 a-b 5 1.3.2 a-b Additional tables, to help you summarizing the data: 6 7 8 Title Progress towards measles and rubella elimination 2018 Number of measles and rubella cases in 2018 Number of measles/rubella/CRS cases, by case classification and origin of infection Measles / Rubella outbreaks and sporadic cases in 2018 by availability of the genotype information Number of suspected cases tested in 2018 by type of the laboratory Measles surveillance performance indicators (standard and alternative) Rubella surveillance performance indicators (standard and alternative) you summarizing the data: Measles all cases, by regional level, classification category and month Rubella all cases, by regional level, classification category and month Measles cases by genotypes and sequence variants 2017-2019 Page in original ASU 2018 (empty form) Page 8 Page 9 Pages 9-10 Page 12 Page 15 Page 18 Page 19 Page 20 Note: Use for calculation and populate tables in ASU Use for calculation and populate tables in ASU Use for calculation and populate tables in ASU Use for calculation and populate tables in ASU. Please see also Annex 1.2 for guidelines Use for calculation and populate tables in ASU. Please see also Annex 1.2 for guidelines PLEASE FILL IN ALL THE GREEN HIGHLIGHTED CELLS! 1.1 Progress towards measles and rubella elimination, 2016-2018 Tab 1.1 - only 2018 Fill in here: Number of population (as used for ASU) 1.1.1 Epidemiology of measles, rubella and CRS in 2018 Tab 1.1.1 c Number of measles and rubella cases in 2018 Total cases classified* as Total suspected cases measles and rubella (calculated automatically) (calculated automatically from Tab 1.1.1 d-e) Measles 0 0 Rubella 0 0 * Total of laboratory-confirmed, epidemiologically linked and clinically compatible cases, regardless of origin (include imported). Tab 1.1.1 d Number of measles cases, by case classification and origin of infection Measles cases classified as Laboratory-confirmed Epidemiologically linked Imported Import-related Endemic Unknown Total (excluding imported cases) 0 0 (calculated automatically) Tab 1.1.1 e Number of rubella cases, by case classification and origin of infection Rubella cases classified as Laboratory-confirmed Epidemiologically linked Imported Import-related Endemic Unknown Total (excluding imported cases) (calculated automatically) 0 0 Tab 1.1.1 f Number of CRS cases, by case classification and origin of infection CRS cases classified as Laboratory-confirmed Epidemiologically linked Imported Import-related Endemic Unknown Total (excluding imported cases) 0 0 (calculated automatically) (calculated automatically after completing Tab 1.1 - only 2018 tables 1.1.1 d-f) Incidence / No of cases 2018 Measles incidence per 1 million population #DIV/0! Rubella incidence per 1 million population #DIV/0! Number of CRS cases 0 Remarks Discarded If number of your suspected cases differs from the automatically calculated, please note here: mported). Total Clinically compatible (calculated automatically) 0 0 0 0 0 0 Total Clinically compatible (calculated automatically) 0 0 0 0 0 0 Total Clinically compatible (calculated automatically) 0 0 0 0 0 0 1.1.4 Outbreaks in 2018 Tab 1.1.4.1 a Measles outbreaks and sporadic cases in 2018 by availability of the genotype information Genotyped Number of outbreaks/chains of transmission Number of cases in the outbreaks/chains of transmission Number of sporadic cases that are not part of chains of transmission Total number of cases (calculated automatically) Tab 1.1.4.2 a Rubella outbreaks and sporadic cases in 2018 by availability of the genotype information Genotyped Number of outbreaks/chains of transmission Number of cases in the outbreaks/chains of transmission Number of sporadic cases that are not part of chains of transmission Total number of cases (calculated automatically) 18 by availability of the genotype information Not genotyped Total 0 0 0 0 18 by availability of the genotype information Not genotyped Total 0 0 0 0 1.2 Laboratory performance Tab 1.2. c Number of suspected cases tested in 2018 by type of the laboratory Laboratory performing the Number of suspected cases tested Number of suspected cases tested test for measles for rubella WHO-accredited lab(s) Proficient labs overseen by WHO- accredited lab Nationally accredited labs Other labs Total 0 0 (calculated automatically) ratory Number of suspected cases tested for CRS 0 1.3.1 Measles surveillance performance indicators ad 1.3.1 a Standard indicators Measles Fill in here: Number of reports submitted by the deadline Number of submitted reports Number of expected reports Number of suspected measles cases with adequate specimens collected and tested in a proficient laboratory 0 (automatically filled in) Number of suspected cases (automatically filled in (FUNCTION FORMULA ='Tab 1.1 & 1.1.1 c-f'!C12) BUT you can decrease the number removing confirmed epidemiologicaly linked cases or cases discarded as non-measles by 0 epidemiological linkage to a laboratory-confirmed case of another communicable disease or epidemiological linkage to a measles IgM-negative case) Number of suspected measles cases investigated and discarded as non-measles cases 0 (automatically filled in) Population 0 (automatically filled in) Number of subnational administrative territories reporting the rate of discarded cases at least 2 per 100 000 population per year Number of subnational administrative territories Number of chains of transmission of measles for which adequate samples have been 0 submitted for viral detection / genotyping (automatically filled in) Number of chains of transmission identified 0 (automatically filled in) Number of measles cases for which the origin of infection (e.g. imported, import- related or endemic) has been identified 0 (automatically filled in) The total number of measles cases 0 (automatically filled in) Number of measles cases with an adequate investigation Number of suspected measles cases 0 (automatically filled in) ad 1.3.1 b Alternative indicators Measles Fill in here: Number of reports submitted within 48 hours Number of suspected cases 0 (automatically filled in) Number of measles-like cases tested negative for measles IgM Population 0 (automatically filled in) Tab 1.3.1 a Standard indicators (automatically calculated) Notes: Measles Regular monthly or weekly reports, including “zero” reports to be Timeliness of reporting (to submitted by each surveillance reporting unit to national level. This does not refer to lab reporting of cases. The deadline to submit data on the national level) (in %) previous months or week to be defined by Member State. Completeness of reporting (to national level) (in %) Rate of laboratory investigations (in %) A single clinical sample obtained at the first contact with the health-care system at any time within 28 days after rash onset is considered adequate for surveillance purposes.Laboratory that is WHO accredited Rate of discarded cases and/or has an established quality assurance programme with oversight by a WHO accredited laboratory. Exclude from the number any suspected cases not tested by a laboratory and (a) confirmed by epidemiological linkage, or Representativeness of reporting (b) discarded as non-measles by epidemiological linkage to a laboratory- discarded cases confirmed case of another communicable disease or epidemiological (in %) linkage to a measles IgM-negative case Viral detection (in %) Origin of infection identified (in %) Timeliness of investigation (in %) Measles viruses can be detected in nasal secretions, urine, serum and whole blood, and dry blood spots up to seven days after onset of the rash and in oral fluid for even longer . An adequate investigation includes the collection of at least the following essential data elements from each suspected measles case: case identifier, age (or date of birth), date of rash onset, date of specimen collection and vaccination status. Countries may wish to collect other data that may be important for epidemiologic investigation. Tab 1.3.1 b Alternative indicators (automatically calculated) Measles Timeliness of notification (in %; alternative to Timeliness and Completeness indicator) Rate of cases tested negative for measles IgM (N) tandard indicators (automatically calculated) Value, rate or Numerator Denominator Description percentage Percentage of measles routine surveillance reports submitted to the not applicable 0 0 national level by the deadline Percentage of measles routine surveillance reports submitted to the not applicable 0 0 national level Percentage of cases suspected for measles with adequate not applicable 0 0 specimensc collected and tested in a WHO accredited or proficient laboratory The rate of suspected measles cases investigated and discarded as not applicable 0 0 non-measles cases using laboratory testing in a proficient laboratory and/or epidemiological linkage to another confirmed disease Percentage of subnational administrative territories (e.g. at the not applicable 0 0 province level or its administrative equivalent) reporting the rate of discarded cases at least 2 per 100 000 population per year Percentage of laboratory-confirmed chains of transmission of not applicable 0 0 measles with samples adequate for viral detection collected and tested in an accredited laboratory Percentage of measles cases for which the origin of infection not applicable 0 0 (e.g. imported, import-related or endemic) has been identified Percentage of suspected measles cases with an adequate not applicable 0 0 investigation initiated within 48 hours of notification lternative indicators (automatically calculated) Rate or Numerator Denominator Description percentage Alternative to Timeliness and Completeness of reporting not applicable 0 0 Percentage of measles case-based reports to surveillance system submitted within 48 hours of the rash onset Alternative to Rate of discarded cases not applicable 0 0 The rate of cases of measles-like illnesses (MLI) whose specimens tested IgM negative in a proficient laboratory 1.3.2 Rubella surveillance performance indicators ad 1.3.2 a Standard indicators Rubella Number of reports submitted by the deadline Number of submitted reports Number of expected reports Number of suspected rubella cases with adequate specimens collected and tested in a proficient laboratory (automatically filled in) Number of suspected cases (automatically filled in (FUNCTION FORMULA IS ='Tab 1.1 & 1.1.1 c-f'!C13) BUT you can decrease the number by removing confirmed epidemiologically linked cases or discarded as non-rubella by epidemiological linkage to a laboratory-confirmed case of another communicable disease or epidemiological linkage to a rubella IgM-negative case) Number of suspected rubella cases investigated and discarded as non-rubella cases (automatically filled in) Population (automatically filled in) Number of subnational administrative territories reporting the rate of discarded cases at least 2 per 100 000 population per year Number of subnational administrative territories Number of chains of transmission of rubella for which adequate samples have been submitted for viral detection / genotyping (automatically filled in) Number of chains of transmission identified (automatically filled in) Number of rubella cases for which the origin of infection (e.g. imported, import-related or endemic) has been identified (automatically filled in) The total number of rubella cases (automatically filled in) Number of rubella cases with an adequate investigation Number of suspected rubella cases (automatically filled in) ad 1.3.2 b Alternative indicators Rubella Number of reports submitted within 48 hours Number of suspected cases (automatically filled in) Number of rubella cases tested negative for rubella IgM Population (automatically filled in) Fill in here: Notes: Regular monthly or weekly reports, including “zero” reports to be submitted by each surveillance reporting unit to national level. This does not refer to lab reporting of cases. The deadline to submit data on the previous months or week to be defined by Member State A single clinical sample obtained at the first contact with the health-care system at any time within 28 days after rash onset is considered adequate for surveillance purposes. 0 Laboratory that is WHO accredited and/or has an established quality assurance programme with oversight by a WHO accredited laboratory. Exclude from the number any suspected cases not tested by a laboratory and (a) confirmed by epidemiological linkage, or 0 (b) discarded as non-rubella by epidemiological linkage to a laboratory-confirmed case of another communicable disease or epidemiological linkage to a rubella IgM-negative case 0 0 Rubella viruses can be detected in nasal secretions, urine, serum and whole blood, and dry 0 blood spots up to seven days after onset of the rash and in oral fluid for even longer . 0 0 0 An adequate investigation includes the collection of at least the following essential data elements from each suspected rubella case: case identifier, age (or date of birth), date of rash onset, date of specimen collection and vaccination status. Countries may wish to collect other data that may be important for epidemiologic investigation 0 Fill in here: 0 0 Tab 1.3.2 a Standard indicators (automatically calculated) Rubella Value, rate or percentage Numerator Denominator Timeliness of reporting (to national level) (in %) not applicable 0 0 Completeness of reporting (to national level) not applicable 0 0 (in %) Rate of laboratory investigations (in %) not applicable 0 0 Rate of discarded cases not applicable 0 0 Representativeness of reporting discarded cases not applicable 0 0 (in %) Viral detection (in %) not applicable 0 0 Origin of infection identified not applicable 0 0 (in %) Timeliness of investigation (in %) not applicable 0 0 Tab 1.3.2 b Alternative indicators (automatically calculated) Rubella Value, rate or percentage Numerator Denominator Timeliness of notification (in %; alternative to not applicable 0 0 Timeliness and Completeness indicator) Rate of cases tested negative for rubella IgM not applicable 0 0 (N) Description Percentage of rubella routine surveillance reports submitted to the national level by the deadline Percentage of rubella routine surveillance reports submitted to the national level Percentage of cases suspected for rubella with adequate specimens collected and tested in a WHO accredited or proficient laboratory The rate of suspected rubella cases investigated and discarded as non-rubella cases using laboratory testing in a proficient laboratory and/or epidemiological linkage to another confirmed disease Percentage of subnational administrative territories (e.g. at the province level or its administrative equivalent) reporting the rate of discarded cases at least 2 per 100 000 population per year Percentage of laboratory-confirmed chains of transmission of rubella with samples adequate for viral detection collected and tested in an accredited laboratory Percentage of rubella cases for which the origin of infection (e.g. imported, import- related or endemic) has been identified Percentage of suspected rubella cases with an adequate investigation initiated within 48 hours of notification Description Alternative to Timeliness and Completeness of reporting Percentage of rubella case-based reports to surveillance system submitted within 48 hours of the rash onset Alternative to Rate of discarded cases The rate of cases of rubella-like illnesses (RLI) whose specimens tested IgM negative in a proficient laboratory Measles 2018 - number of cases Jan Feb Mar Suspected (calculated automatically) 0 0 0 Discarded Classified as measles (calculated automatically) 0 0 0 National level Clinical (population) Epid-link Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as (calculated automatically) 0 0 0 administrative level - Clinical no. 1 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as measles (calculated automatically) 0 0 0 administrative level - Clinical no. 2 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as measles (calculated automatically) 0 0 0 administrative level - Clinical no. 3 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as measles (calculated automatically) 0 0 0 administrative level - Clinical no. 4 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases add as many as subnational administrative units of that level you have in country national level data should be sum of subnational level data Apr May Jun Jul Aug Sep Oct Nov Dec 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Total Rules (calculated automatically) 0 0 Suspected = Discarded + Classified as 0 Classified as measles = Clinical + Epid-link + 0 0 0 Classified as measles = Outbreak cases + Sporadic cases 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Lab confirmed Rubella 2018 - number of cases Jan Feb Mar Suspected (calculated automatically) 0 0 0 Discarded Classified as rubella (calculated automatically) 0 0 0 National level Clinical (population) Epid-link Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as rubella (calculated automatically) 0 0 0 administrative level - Clinical no. 1 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as rubella (calculated automatically) 0 0 0 administrative level - Clinical no. 2 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as rubella (calculated automatically) 0 0 0 administrative level - Clinical no. 3 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases Suspected (calculated automatically) 0 0 0 Discarded 1st subnational Classified as rubella (calculated automatically) 0 0 0 administrative level - Clinical no. 4 Epid-link (population) Lab confirmed Outbreak cases Sporadic cases add as many as subnational administrative units of that level you have in country national level data should be sum of subnational level data Apr May Jun Jul Aug Sep Oct Nov Dec 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Total Rules (calculated automatically) 0 0 Suspected = Discarded + Classified as 0 Classified as rubella = Clinical + Epid-link + 0 0 0 Classified as rubella = Outbreak cases + Sporadic cases 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Lab confirmed Measles cases by genotypes and sequence variants 2017-2019 Genotype Sequence variant Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases National level Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases 1st administrative level - Outbreak cases no. 1 Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases 1st administrative level - no. 2 Sporadic cases Outbreak cases Sporadic cases 1st administrative level - Outbreak cases no. 2 Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases 1st administrative level - Outbreak cases no. 3 Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases 1st administrative level - Outbreak cases no. 4 Sporadic cases Outbreak cases Sporadic cases Outbreak cases no. 4 Sporadic cases Outbreak cases Sporadic cases Outbreak cases Sporadic cases add as many as subnational administrative units of that level you have in country add/remove genotype and variant data as per their detection at subnational level national level data should be sum of subnational level data -2019 okt.17 nov.17 dets.17 jaan.18 veebr.18 märts.18 apr.18 mai.18 juuni.18 juuli.18 aug.18 sept.18 okt.18 nov.18 dets.18 jaan.19 veebr.19 märts.19 Saatja: Elen Ohov <[email protected]> Saadetud: 08.03.2019 13:31 Adressaat: SM Info <[email protected]> Teema: FW: Annual status update on measles and rubella elimination-2018 CRM:0081049 Manused: Annual status update on measles and rubella elimination.pdf; ENG ASU 2018.docx; ENG Excel tool ASU 2018.xlsx From: Florencia Biviano <[email protected]> Sent: Tuesday, March 5, 2019 3:45 PM To: Elen Ohov <[email protected]> Cc: Andre Pung <[email protected]>; EURO RVC <[email protected]>; Marge Reinap <[email protected]>; Märt Volmer <[email protected]>; Triin Uusberg <[email protected]> Subject: Annual status update on measles and rubella elimination-2018 CRM:0081049 Please see the attached correspondence sent from the World Health Organization, Regional Office for Europe. One or more attachments may be included. Veuillez vous référer à la correspondance ci-jointe du Bureau régional de l'Europe de l'Organisation mondiale de la santé. Une ou plusieurs annexes peuvent être jointes. Mit der Bitte um Kenntnisnahme der beiliegenden Korrespondenz (eine oder mehrere Anlagen), Weltgesundheitsorganisation, Regionalbüro für Europa См. прикрепленные письма от Европейского регионального бюро Всемирной организации здравоохранения (один или несколько прикрепленных файлов). WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ WELTGESUNDHEITSORGANISATION Date: 05 March 2019 ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ REGIONAL OFFICE FOR EUROPE Ms Elen Ohov BUREAU RÉGIONAL DE L’EUROPE REGIONALBÜRO FÜR EUROPA Adviser ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co- Head office: operation Department UN City, Marmorvej 51, Ministry of Social Affairs DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1 Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Email: [email protected] 10122 Tallinn Website: http://www.euro.who.int Estonia Our reference: Your reference: Notre référence: Votre référence: Unser Zeichen: Ihr Zeichen: См. наш номер: На Ваш номер: Dear Ms Ohov, Annual status update (ASU) on measles and rubella elimination – 2018 The Vaccine-preventable Diseases and Immunization programme (VPI) of the WHO Regional Office for Europe is pleased to inform you that the eighth meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) will be held in June 2019, to review status and achievements towards measles and rubella elimination in countries and in the Region. The RVC will base its decision on the status of measles and rubella elimination in each Member State and the Region on three consecutive reports submitted by the respective national verification committees (NVCs). All Member States are requested to submit their ASU on measles and rubella elimination activities for the year 2018 with all relevant information no later than 15 April 2019. Adhering to this deadline is essential to ensure sufficient time for the analysis of data before the RVC meets. An ASU template for 2018 and all additional documents, prepared and approved by the respective NVC, should be submitted via SharePoint or by e-mail ([email protected]) to the WHO Regional Office for Europe (RVC Secretariat). We kindly ask you to use the credentials and instructions for using SharePoint as previously provided. Attached you will find a template for the 2018 ASU. To ensure consistency, please follow the proposed format as explained in the instructions. To facilitate your work on preparation of the ASU 2018, please use an Excel file and its pre-prepared tables with formulas that will help you in calculating data. A few extra worksheets are developed to facilitate analysis of data at subnational level and to allow presenting detailed molecular epidemiology information if available, for your convenience. We recommend to submit this file together with ASU 2018. In addition, we encourage you to submit any additional information that will assist the RVC in determining the status of measles and rubella elimination in your country. Additional information that does not fit in the template may be uploaded as a separate document. VPI stands ready to support you in ensuring timely completion of the ASU. UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int Denmark We would like to take this opportunity to re-emphasize the importance of ensuring that data submitted in this annual update are accurate and consistent with other national reports submitted to the Regional Office. We would also like to stress that all reports and additional information received from the NVCs during the verification process will be carefully reviewed and analysed. RVC conclusions based on this information will be publicly presented in various forms, as part of planned communication activities to recognize Member States’ efforts and progress towards the Region’s immunization goals. Should you have any questions regarding the provided template and uploading of documents, please contact Dr Dragan Jankovic ([email protected]), Dr Zhanara Bekenova ([email protected]) and Ms Florencia Biviano ([email protected]). We would like to stress that your efforts in documenting the absence of endemic transmission in your country are highly appreciated and critical to achieving measles and rubella elimination in the Region. The RVC and Secretariat are committed to providing you with any support that you may require. Sincerely yours, Dr Siddhartha Datta Programme Manager Vaccine-preventable Diseases and Immunization Copy for information to: Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs, Suur-Ameerika 1, 10129 Tallinn, Estonia H.E. Mr Andre Pung, Ambassador, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, CH-1209 Genève, Switzerland H.E. Mr Märt Volmer, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark Ms Marge Reinap, Head of WHO Office, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia EURO RVC, World Health Organization Regional Office for Europe, Denmark –2–
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel